Elastomeric Infusion Pumps Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research, a renowned market research firm, has conducted an in-depth analysis of the global Elastomeric Infusion Pumps Market. This comprehensive report provides valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. It offers a detailed overview of the elastomeric infusion pumps segment within the healthcare industry, presenting exclusive data and statistics projecting the market's growth trajectory from 2024 to 2031.

Key Insights:

Elastomeric Infusion Pumps Market Size (2024): US$ 1.10 Bn
Projected Market Value (2031): US$ 3.11 Bn
Global Market Growth Rate (CAGR 2024 to 2031): 9.0%

Elastomeric Infusion Pumps Market - Report Scope:

The Elastomeric Infusion Pumps Market encompasses a range of disposable, portable, and ambulatory infusion devices used for the continuous and controlled delivery of medications, fluids, and nutrients to patients in various healthcare settings. This market serves hospitals, clinics, home healthcare providers, and ambulatory care centers, offering elastomeric pumps for intravenous (IV) therapy, pain management, antibiotic administration, and chemotherapy. Elastomeric infusion pumps utilize elastomeric membranes or balloons to provide accurate and consistent drug delivery rates over extended periods, minimizing the need for frequent manual adjustments and reducing the risk of medication errors. Market growth is driven by increasing prevalence of chronic diseases, rising demand for home-based infusion therapy, and technological advancements in pump design and drug delivery systems.

Market Growth Drivers:

The global Elastomeric Infusion Pumps Market benefits from several key growth drivers. The growing prevalence of chronic conditions, such as cancer, diabetes, and autoimmune disorders, fuels demand for long-term infusion therapy and pain management solutions, driving market expansion. Moreover, the shift towards home-based healthcare and outpatient treatment models creates opportunities for elastomeric infusion pumps to provide safe, cost-effective, and convenient drug delivery options for patients outside of traditional hospital settings. Furthermore, advancements in pump technology, including integrated safety features, customizable flow rates, and wireless connectivity, enhance pump usability, patient comfort, and treatment outcomes, driving market adoption. Additionally, the expansion of infusion therapy indications and the introduction of specialty drugs requiring continuous infusion further stimulate market growth.

Market Restraints:

Despite its promising growth prospects, the Elastomeric Infusion Pumps Market faces challenges related to regulatory compliance, reimbursement policies, and competitive pressures. Regulatory requirements governing the manufacturing, marketing, and use of infusion pumps impose compliance burdens on manufacturers and healthcare providers, affecting market entry barriers and operational costs. Moreover, reimbursement limitations for home infusion therapy and specialty drugs may restrict patient access to elastomeric pumps and related services, particularly in regions with constrained healthcare budgets. Additionally, intense competition from alternative drug delivery devices, such as electronic infusion pumps and implantable ports, may impact market share and pricing dynamics. Addressing these barriers requires collaboration between industry stakeholders and policymakers to promote access to safe, affordable, and high-quality infusion therapy solutions.

Market Opportunities:

The Elastomeric Infusion Pumps Market presents significant growth opportunities driven by technological innovations, market expansion, and patient-centric care models. Emerging trends such as telemedicine, remote patient monitoring, and digital health platforms enable healthcare providers to remotely monitor infusion therapy patients, optimize treatment regimens, and enhance patient outcomes. Furthermore, the development of specialty elastomeric pumps for targeted drug delivery, pain management, and palliative care creates new market segments and revenue streams for manufacturers and service providers. Moreover, strategic partnerships with pharmaceutical companies, home infusion providers, and healthcare payers facilitate market access, product differentiation, and value-based care initiatives, driving market growth and innovation.

Key Questions Answered in the Report:

What factors are driving the growth of the Elastomeric Infusion Pumps Market globally?
How are advancements in pump technology and drug delivery systems reshaping the competitive landscape of elastomeric infusion pumps?
What are the key challenges and opportunities facing market participants in the elastomeric infusion pump segment?
Which patient populations and therapeutic indications offer the highest growth potential for elastomeric infusion therapy?
What strategies are leading companies employing to maintain their competitive edge and drive innovation in the market?

Competitive Intelligence and Business Strategy:

Leading players in the global Elastomeric Infusion Pumps Market, including medical device manufacturers, pharmaceutical companies, and home infusion providers, focus on innovation, market expansion, and patient engagement to drive growth and differentiate their offerings. These companies invest in research and development to develop next-generation elastomeric pump technologies, drug formulations, and infusion protocols tailored to specific therapeutic indications and patient populations. Moreover, strategic partnerships with healthcare providers, payers, and technology vendors enable companies to integrate infusion therapy solutions into value-based care models and population health management initiatives. Furthermore, emphasis on patient education, training, and support services enhances treatment adherence, patient satisfaction, and clinical outcomes in the competitive landscape of home infusion therapy.

Key Companies Profiled:

Baxter International, Inc.
Fresenius Kabi AG
B. Braun Melsungen AG
Ambu A/S
Leventon, S.A.U.
Nipro Corporation
Terumo Corporation
Avanos Medical, Inc.

Elastomeric Infusion Pumps Market Research Segmentation:

Elastomeric Infusion Pumps Market by Product:

Continuous Rate Elastomeric Pumps
Variable Rate Elastomeric Pumps

Elastomeric Infusion Pumps Market by Treatment:

Pain Management
Antibiotic/Antiviral
Chemotherapy
Others

Elastomeric Infusion Pumps Market by End User:

Hospitals
Ambulatory Surgical Centers
Home Care Settings
Clinics
Others

Elastomeric Infusion Pumps Market by Region:

North America Elastomeric Infusion Pumps Market
Latin America Elastomeric Infusion Pumps Market
Europe Elastomeric Infusion Pumps Market
East Asia Elastomeric Infusion Pumps Market
South Asia Elastomeric Infusion Pumps Market
Oceania Elastomeric Infusion Pumps Market
Middle East and Africa (MEA) Elastomeric Infusion Pumps Market

Product Code: PMRREP11032

1. Executive Summary

1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Definition
2.2. Market Taxonomy

3. Elastomeric Infusion Pumps Market View Point

3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Global Trends
3.4. Regulatory Scenario
3.5. Hazard Analysis - Elastomeric Pumps
3.6. High Competition from Electronic Ambulatory Pumps - Industry Insights
3.7. Elastomeric pumps posing competition to PCA Pumps - Industry Insights
3.8. Criteria Determining Product Popularity - Industry Insights
3.9. Fluorouracil Incident of August 2006 - ISMP Canada Root Cause Analysis
3.10. Contamination Incident at Lapeyronie University Hospital, France, October 2008
3.11. Global Continuous Rate Elastomeric Pumps Price Forecast By Region
3.12. Global Pricing Analysis By Manufacturer
3.13. Global Sales Volume, By Manufacturer

4. North America Elastomeric Infusion Pumps Market Analysis 2012-2023 and Forecast 2022-2030

4.1. Introduction
4.2. Regional Market Dynamics
- 4.2.1. Drivers
- 4.2.2. Restraints
- 4.2.3. Trends
4.3. Historical Market Size (US$ Mn) By Country, 2012-2023
- 4.3.1. U.S.
- 4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2022-2030
- 4.4.1. U.S.
- 4.4.2. Canada
4.5. Historical Market Size (US$ Mn) By Product Type, 2012-2023
- 4.5.1. Continuous Rate Elastomeric Pumps
- 4.5.2. Variable Rate Elastomeric Pumps
4.6. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
- 4.6.1. Continuous Rate Elastomeric Pumps
- 4.6.2. Variable Rate Elastomeric Pumps
4.7. Historical Market Size (US$ Mn) By Treatment Type, 2012-2023
- 4.7.1. Pain Management
- 4.7.2. Antibiotic/Antiviral
- 4.7.3. Chemotherapy
- 4.7.4. Others
4.8. Market Size (US$ Mn) Forecast By Treatment Type, 2024-2031
- 4.8.1. Pain Management
- 4.8.2. Antibiotic/Antiviral
- 4.8.3. Chemotherapy
- 4.8.4. Others
4.9. Historical Market Size (US$ Mn) By End User, 2012-2023
- 4.9.1. Hospitals
- 4.9.2. Ambulatory Surgical Centers
- 4.9.3. Home Care Settings
- 4.9.4. Clinics
- 4.9.5. Other
4.10. Market Size (US$ Mn) Forecast By End User, 2024-2031
- 4.10.1. Hospitals
- 4.10.2. Ambulatory Surgical Centers
- 4.10.3. Home Care Settings
- 4.10.4. Clinics
- 4.10.5. Other
4.11. Drivers and Restraints: Impact Analysis
4.12. Market Attractiveness Analysis
- 4.12.1. By Product
- 4.12.2. By Treatment Type
- 4.12.3. By End User
- 4.12.4. By Country

5. Latin America Elastomeric Infusion Pumps Market Analysis 2012-2023 and Forecast 2024-2031

5.1. Introduction
5.2. Regional Market Dynamics
- 5.2.1. Drivers
- 5.2.2. Restraints
- 5.2.3. Trends
5.3. Historical Market Size (US$ Mn) By Country, 2012-2023
- 5.3.1. Brazil
- 5.3.2. Mexico
- 5.3.3. Rest of Latin America
5.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
- 5.4.1. Brazil
- 5.4.2. Mexico
- 5.4.3. Rest of Latin America
5.5. Historical Market Size (US$ Mn) By Product Type, 2012-2023
- 5.5.1. Continuous Rate Elastomeric Pumps
- 5.5.2. Variable Rate Elastomeric Pumps
5.6. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
- 5.6.1. Continuous Rate Elastomeric Pumps
- 5.6.2. Variable Rate Elastomeric Pumps
5.7. Historical Market Size (US$ Mn) By Treatment Type, 2012-2023
- 5.7.1. Pain Management
- 5.7.2. Antibiotic/Antiviral
- 5.7.3. Chemotherapy
- 5.7.4. Others
5.8. Market Size (US$ Mn) Forecast By Treatment Type, 2024-2031
- 5.8.1. Pain Management
- 5.8.2. Antibiotic/Antiviral
- 5.8.3. Chemotherapy
- 5.8.4. Others
5.9. Historical Market Size (US$ Mn) By End User, 2012-2023
- 5.9.1. Hospitals
- 5.9.2. Ambulatory Surgical Centers
- 5.9.3. Home Care Settings
- 5.9.4. Clinics
- 5.9.5. Other
5.10. Market Size (US$ Mn) Forecast By End User, 2024-2031
- 5.10.1. Hospitals
- 5.10.2. Ambulatory Surgical Centers
- 5.10.3. Home Care Settings
- 5.10.4. Clinics
- 5.10.5. Other
5.11. Drivers and Restraints: Impact Analysis
5.12. Market Attractiveness Analysis
- 5.12.1. By Product
- 5.12.2. By Treatment Type
- 5.12.3. By End User
- 5.12.4. By Country

6. Europe Elastomeric Infusion Pumps Market Analysis 2012-2023 and Forecast 2024-2031

6.1. Introduction
6.2. Regional Market Dynamics
- 6.2.1. Drivers
- 6.2.2. Restraints
- 6.2.3. Trends
6.3. Historical Market Size (US$ Mn) By Country, 2012-2023
- 6.3.1. Germany
- 6.3.2. U.K.
- 6.3.3. France
- 6.3.4. Italy
- 6.3.5. Spain
- 6.3.6. Poland
- 6.3.7. Russia
- 6.3.8. Rest of Europe
6.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
- 6.4.1. Germany
- 6.4.2. U.K.
- 6.4.3. France
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Poland
- 6.4.7. Russia
- 6.4.8. Rest of Europe
6.5. Historical Market Size (US$ Mn) By Product Type, 2012-2023
- 6.5.1. Continuous Rate Elastomeric Pumps
- 6.5.2. Variable Rate Elastomeric Pumps
6.6. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
- 6.6.1. Continuous Rate Elastomeric Pumps
- 6.6.2. Variable Rate Elastomeric Pumps
6.7. Historical Market Size (US$ Mn) By Treatment Type, 2012-2023
- 6.7.1. Pain Management
- 6.7.2. Antibiotic/Antiviral
- 6.7.3. Chemotherapy
- 6.7.4. Others
6.8. Market Size (US$ Mn) Forecast By Treatment Type, 2024-2031
- 6.8.1. Pain Management
- 6.8.2. Antibiotic/Antiviral
- 6.8.3. Chemotherapy
- 6.8.4. Others
6.9. Historical Market Size (US$ Mn) By End User, 2012-2023
- 6.9.1. Hospitals
- 6.9.2. Ambulatory Surgical Centers
- 6.9.3. Home Care Settings
- 6.9.4. Clinics
- 6.9.5. Other
6.10. Market Size (US$ Mn) Forecast By End User, 2024-2031
- 6.10.1. Hospitals
- 6.10.2. Ambulatory Surgical Centers
- 6.10.3. Home Care Settings
- 6.10.4. Clinics
- 6.10.5. Other
6.11. Drivers and Restraints: Impact Analysis
6.12. Market Attractiveness Analysis
- 6.12.1. By Product
- 6.12.2. By Treatment Type
- 6.12.3. By End User
- 6.12.4. By Country

7. Asia Pacific (APAC) Elastomeric Infusion Pumps Market Analysis 2012-2023 and Forecast 2024-2031

7.1. Introduction
7.2. Regional Market Dynamics
- 7.2.1. Drivers
- 7.2.2. Restraints
- 7.2.3. Trends
7.3. Historical Market Size (US$ Mn) By Country, 2012-2023
- 7.3.1. China
- 7.3.2. India
- 7.3.3. Japan
- 7.3.4. Australia & New Zealand
- 7.3.5. Rest of APAC
7.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
- 7.4.1. China
- 7.4.2. India
- 7.4.3. Japan
- 7.4.4. Australia & New Zealand
- 7.4.5. Rest of APAC
7.5. Historical Market Size (US$ Mn) By Product Type, 2012-2023
- 7.5.1. Continuous Rate Elastomeric Pumps
- 7.5.2. Variable Rate Elastomeric Pumps
7.6. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
- 7.6.1. Continuous Rate Elastomeric Pumps
- 7.6.2. Variable Rate Elastomeric Pumps
7.7. Historical Market Size (US$ Mn) By Treatment Type, 2012-2023
- 7.7.1. Pain Management
- 7.7.2. Antibiotic/Antiviral
- 7.7.3. Chemotherapy
- 7.7.4. Others
7.8. Market Size (US$ Mn) Forecast By Treatment Type, 2024-2031
- 7.8.1. Pain Management
- 7.8.2. Antibiotic/Antiviral
- 7.8.3. Chemotherapy
- 7.8.4. Others
7.9. Historical Market Size (US$ Mn) By End User, 2012-2023
- 7.9.1. Hospitals
- 7.9.2. Ambulatory Surgical Centers
- 7.9.3. Home Care Settings
- 7.9.4. Clinics
- 7.9.5. Other
7.10. Market Size (US$ Mn) Forecast By End User, 2024-2031
- 7.10.1. Hospitals
- 7.10.2. Ambulatory Surgical Centers
- 7.10.3. Home Care Settings
- 7.10.4. Clinics
- 7.10.5. Other
7.11. Drivers and Restraints: Impact Analysis
7.12. Market Attractiveness Analysis
- 7.12.1. By Product
- 7.12.2. By Treatment Type
- 7.12.3. By End User
- 7.12.4. By Country

8. Middle East and Africa (MEA) Elastomeric Infusion Pumps Market Analysis 2012-2023 and Forecast 2024-2031

8.1. Introduction
8.2. Regional Market Dynamics
- 8.2.1. Drivers
- 8.2.2. Restraints
- 8.2.3. Trends
8.3. Historical Market Size (US$ Mn) By Country, 2012-2023
- 8.3.1. GCC Countries
- 8.3.2. South Africa
- 8.3.3. Rest of MEA
8.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
- 8.4.1. GCC Countries
- 8.4.2. South Africa
- 8.4.3. Rest of MEA
8.5. Historical Market Size (US$ Mn) By Product Type, 2012-2023
- 8.5.1. Continuous Rate Elastomeric Pumps
- 8.5.2. Variable Rate Elastomeric Pumps
8.6. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
- 8.6.1. Continuous Rate Elastomeric Pumps
- 8.6.2. Variable Rate Elastomeric Pumps
8.7. Historical Market Size (US$ Mn) By Treatment Type, 2012-2023
- 8.7.1. Pain Management
- 8.7.2. Antibiotic/Antiviral
- 8.7.3. Chemotherapy
- 8.7.4. Others
8.8. Market Size (US$ Mn) Forecast By Treatment Type, 2024-2031
- 8.8.1. Pain Management
- 8.8.2. Antibiotic/Antiviral
- 8.8.3. Chemotherapy
- 8.8.4. Others
8.9. Historical Market Size (US$ Mn) By End User, 2012-2023
- 8.9.1. Hospitals
- 8.9.2. Ambulatory Surgical Centers
- 8.9.3. Home Care Settings
- 8.9.4. Clinics
- 8.9.5. Other
8.10. Market Size (US$ Mn) Forecast By End User, 2024-2031
- 8.10.1. Hospitals
- 8.10.2. Ambulatory Surgical Centers
- 8.10.3. Home Care Settings
- 8.10.4. Clinics
- 8.10.5. Other
8.11. Drivers and Restraints: Impact Analysis
8.12. Market Attractiveness Analysis
- 8.12.1. By Product
- 8.12.2. By Treatment Type
- 8.12.3. By End User
- 8.12.4. By Country

9. Assumptions and Acronyms Used

10. Competition Landscape

10.1. Competitive Landscape of Elastomeric Infusion Pumps Manufacturers
10.2. Upcoming Trends Feasibility Analysis
10.3. Porter's Five Forces Analysis - Global Perspective
10.4. Market Maturity Analysis
10.5. Key Insights from Primary Discussions
10.6. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 10.6.1. Baxter International, Inc.
  - 10.6.1.1. Overview
  - 10.6.1.2. Financials
  - 10.6.1.3. Strategy
  - 10.6.1.4. Recent Developments
- 10.6.2. Fresenius Kabi AG
  - 10.6.2.1. Overview
  - 10.6.2.2. Financials
  - 10.6.2.3. Strategy
  - 10.6.2.4. Recent Developments
- 10.6.3. B. Braun Melsungen AG
  - 10.6.3.1. Overview
  - 10.6.3.2. Financials
  - 10.6.3.3. Strategy
  - 10.6.3.4. Recent Developments
- 10.6.4. Ambu A/S
  - 10.6.4.1. Overview
  - 10.6.4.2. Financials
  - 10.6.4.3. Strategy
  - 10.6.4.4. Recent Developments
- 10.6.5. Leventon, S.A.U.
  - 10.6.5.1. Overview
  - 10.6.5.2. Financials
  - 10.6.5.3. Strategy
  - 10.6.5.4. Recent Developments
- 10.6.6. Nipro Corporation
  - 10.6.6.1. Overview
  - 10.6.6.2. Financials
  - 10.6.6.3. Strategy
  - 10.6.6.4. Recent Developments
- 10.6.7. Terumo Corporation
  - 10.6.7.1. Overview
  - 10.6.7.2. Financials
  - 10.6.7.3. Strategy
  - 10.6.7.4. Recent Developments
- 10.6.8. Avanos Medical, Inc.
  - 10.6.8.1. Overview
  - 10.6.8.2. Financials
  - 10.6.8.3. Strategy
  - 10.6.8.4. Recent Developments

11. Global Elastomeric Infusion Pumps Market Analysis 2012-2023 and Forecast 2024-2031, By Region

11.1. Historical Market Size Analysis 2012-2023, By Region
- 11.1.1. North America
- 11.1.2. Latin America
- 11.1.3. Europe
- 11.1.4. Asia Pacific (APAC)
- 11.1.5. Middle East and Africa (MEA)
11.2. Market Size Analysis 2024-2031, By Region
- 11.2.1. North America
- 11.2.2. Latin America
- 11.2.3. Europe
- 11.2.4. Asia Pacific (APAC)
- 11.2.5. Middle East and Africa (MEA)
11.3. Market Attractiveness Analysis By Region

12. Global Elastomeric Infusion Pumps Market Analysis 2012-2023 and Forecast 2024-2031, By Product

12.1. Historical Market Size (US$ Mn) By Product, 2012-2023
- 12.1.1. Continuous Rate Elastomeric Pumps
- 12.1.2. Variable Rate Elastomeric Pumps
12.2. Market Size (US$ Mn) Forecast By Product, 2024-2031
- 12.2.1. Continuous Rate Elastomeric Pumps
- 12.2.2. Variable Rate Elastomeric Pumps
12.3. Market Attractiveness Analysis By Product

13. Global Elastomeric Infusion Pumps Market Analysis 2012-2023 and Forecast 2024-2031, By Treatment Type

13.1. Historical Market Size (US$ Mn) By Treatment Type, 2012-2023
- 13.1.1. Pain Management
- 13.1.2. Antibiotic/Antiviral
- 13.1.3. Chemotherapy
- 13.1.4. Others
13.2. Market Size (US$ Mn) Forecast By Treatment Type, 2024-2031
- 13.2.1. Pain Management
- 13.2.2. Antibiotic/Antiviral
- 13.2.3. Chemotherapy
- 13.2.4. Others
13.3. Market Attractiveness Analysis By Treatment Type

14. Global Elastomeric Infusion Pumps Market Analysis 2012-2023 and Forecast 2024-2031, By End User

14.1. Historical Market Size (US$ Mn) By End User, 2012-2023
- 14.1.1. Hospitals
- 14.1.2. Ambulatory Surgical Centers
- 14.1.3. Home Care Settings
- 14.1.4. Clinics
- 14.1.5. Other
14.2. Market Size (US$ Mn) Forecast By End User, 2024-2031
- 14.2.1. Hospitals
- 14.2.2. Ambulatory Surgical Centers
- 14.2.3. Home Care Settings
- 14.2.4. Clinics
- 14.2.5. Other
14.3. Market Attractiveness Analysis By End User

15. Global Elastomeric Infusion Pumps Market Analysis 2012-2023 and Forecast 2024-2031

15.1. Market Size and Y-o-Y Growth
15.2. Absolute $ Opportunity